Company Info

TIMA Establishment

TIMA Establishment
Address Alte Churer Strasse 45 FL-9496 Balzers Liechtenstein
Representative Markus Count Matuschka de Greiffenclau


TIMA Tokyo INC was spun off and established in 2019 as the manufacturing and sales company for Oxicut in Japan.

The TIMA Medical Foundation has been supporting medical research and development around the world, especially in areas that are not covered by major pharmaceutical companies.
To date, TIMA has supported projects such as gene therapy for glioma brain tumors, research on reducing the health hazards of alcohol, research on metabolic syndrome (mainly diabetes), inhibition of reactive oxygen species (anti-aging), and development of new antibacterial drugs that do not develop drug resistance.
These researches are mainly based on the results of the research team led by Haruhiko Inufusa.

Established June 21, 2019
Representative Representative Director and Chairman President Sho Tanaka

・Tokyo Head Office
2-28-3 Ebisu, Shibuya-ku, Tokyo SP15 EBISU 3F

・Osaka branch
404-1-9-1 Minamisemba, Chuo-ku,
Osaka city 542-0081

Capital JPY 8 million
Major shareholders European Medical Foundation TIMA
Business description Twendee X Manufacturing and sales

Tokai National University Organization Gifu University, Institute of Advanced Studies, Center for Scientific Research Infrastructure, Department of Antioxidant Research

Special Professor:Haruhiko Inukofusa
Location:1-1 Yanato, Gifu-shi, Gifu 501-1194, 7th Floor, Faculty of Medicine Building 7S33

All of our products were developed at Gifu National University.